Contributions of MTC_Marisol
User contributions·19 logged edits·page 1 of 1
Contributions by MTC_Marisol, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,311 edits includes activity predating the current log.
- 10:30, 13 Apr 2026 (diff | hist) Talk:Adverse effects of GLP-1 receptor agonists 537 +208 /* Precautionary contraindication */ new section
- 16:22, 24 Mar 2026 (diff | hist) SinoPep 18,140 ±0 rm the adjective — an organisation article describes, it does not praise
- 01:06, 2 Mar 2026 (diff | hist) Dual incretin agonist 5,851 ±0 add the discontinued indication with its date
- 05:52, 13 Feb 2026 (diff | hist) Arcuate nucleus 5,251 ±0 add the counter-regulatory glucagon point, sourced
- 00:26, 17 Jan 2026 (diff | hist) VendorInvestigate 5,067 ±0 fix a broken wikilink
- 08:55, 15 Oct 2025 (diff | hist) Talk:Semaglutide 1,233 +93 /* Rodent C-cell findings: how should the label contraindication be framed? */ reply
- 13:12, 14 Oct 2025 (diff | hist) Talk:Semaglutide 811 +156 /* Rodent C-cell findings: how should the label contraindication be framed? */ new section
- 22:29, 19 Sep 2025 (diff | hist) Chain of custody 5,157 +135 add the point that reports reaching this wiki are not a sample of anything
- 08:46, 14 Sep 2025 (diff | hist) Trial data comparison 6,523 +485 m expand §Outcome trials are a different kind of evidence
- 15:43, 12 Sep 2025 (diff | hist) Peptide 6,813 ±0 expand §Peptides as medicines
- 19:09, 6 Jul 2025 (diff | hist) STEP trial programme 5,251 +137 m add the comparator arm — an event rate alone says nothing
- 02:58, 15 Mar 2025 (diff | hist) Aspiration risk under anaesthesia 3,880 +155 give the incidence with its denominator
- 03:14, 13 Mar 2025 (diff | hist) Peptide harm reduction 3,320 +535 m add the year-on-year change with both endpoints stated
- 17:13, 16 Jan 2025 (diff | hist) Weight regain after discontinuation 3,570 ±0 m add the placebo rate next to the treatment rate
- 19:10, 15 Nov 2024 (diff | hist) Beta cell function 3,162 ±0 distinguish the active and total forms of the hormone throughout
- 08:58, 28 Oct 2024 (diff | hist) Aspiration risk under anaesthesia 2,259 ±0 state whether the figure is from a trial or from post-marketing reporting
- 07:21, 22 Oct 2024 (diff | hist) Good manufacturing practice 2,472 +33 m move a stray full stop inside the reference
- 09:36, 18 Oct 2024 (diff | hist) Aspiration risk under anaesthesia 2,259 +1,029 clarify that the rodent finding has not been observed in humans
- 10:26, 5 Sep 2024 (diff | hist) Hypoglycaemia 2,014 +235 add the interaction with the mechanism that explains it